Mediastinal large B-cell lymphoma, extranodal and solid organ sites is a type of non-Hodgkin lymphoma characterized by the proliferation of large B-cells in the mediastinum and other extranodal sites. This condition is clinically significant due to its aggressive nature and potential for systemic involvement. Accurate coding with ICD-10 Code C85.29 facilitates precise diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.
ICD-10 Code C85.29 represents mediastinal large B-cell lymphoma occurring in extranodal and solid organ sites. This code is used when documenting cases of this aggressive lymphoma that may present with symptoms such as lymphadenopathy, fever, and weight loss. It is essential for accurate clinical documentation and billing, particularly in oncology settings.
Mediastinal large B-cell lymphoma is a subtype of non-Hodgkin lymphoma that arises from B-lymphocytes in the mediastinum and can involve other solid organs. The etiology is often linked to genetic mutations and environmental factors, leading to uncontrolled cell proliferation. Prompt medical attention is crucial due to its aggressive behavior and potential for metastasis.
ICD-10 Code C85.29 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with mediastinal large B-cell lymphoma. This code aids in capturing the complexity of the condition in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code C85.29 connects subjective patient reports and objective clinical findings to a formal diagnosis of mediastinal large B-cell lymphoma. This linkage is vital for continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of mediastinal large B-cell lymphoma often requires hospitalization for intensive treatment. Chemotherapy is the primary treatment modality, with potential adjunctive therapies depending on the patient's condition.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C85.29 is critical in medical billing, particularly in oncology and hospital settings, to ensure accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 77014 | Radiologic guidance for placement of a catheter. |
| 36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code C85.29 for Mediastnl large B-cell lymph, extrnod and solid organ sites
What are the common symptoms of mediastinal large B-cell lymphoma?
Common symptoms include persistent cough, chest pain, unexplained weight loss, fever, and night sweats. Patients may also experience fatigue and lymphadenopathy.
How is mediastinal large B-cell lymphoma diagnosed?
Diagnosis typically involves imaging studies such as CT scans and biopsy of the mediastinal mass to confirm the presence of large B-cells.
What is the treatment for mediastinal large B-cell lymphoma?
Treatment usually consists of chemotherapy, often with the R-CHOP regimen, and may include radiation therapy for localized disease.
How does ICD-10 Code C85.29 affect billing?
ICD-10 Code C85.29 is essential for accurate billing in oncology, ensuring that services provided for the diagnosis and treatment of this condition are appropriately reimbursed.
Clinical Notes
SOAP notes
DAP notes
AI medical notes